Skip to main content
An official website of the United States government

nanrilkefusp alfa

A human fusion protein consisting of the cytokine interleukin (IL)-15 and the high-affinity binding sushi+ domain of IL-15 receptor alpha (IL-15Ra), with potential antineoplastic activities. Upon administration, nanrilkefusp alfa activates and increases the levels of natural killer (NK) cells and memory CD8+ T cells. The memory T cells enhance the secretion of the cytokine interferon-gamma (IFN-g), which further potentiates the immune response against tumor cells. This may increase tumor cell killing and decrease tumor cell proliferation. IL-15 regulates CD8+ T and NK cell development, activation and proliferation. Nanrilkefusp alfa is more potent than unmodified IL-15 and does not require endogenous IL-15Ra for its action.
Synonym:IL-15/IL-15 receptor alpha sushi+ domain fusion protein SO-C101
interleukin-15/interleukin-15 receptor alpha sushi+ domain fusion protein SO-C101
interleukin-15/interleukin-15 receptor alpha sushi+ domain fusion protein SOT101
Code name:RLI 15
RLI-15
RLI15
SO C101
SO-C101
SOC101
SOT 101
SOT-101
SOT101
Search NCI's Drug Dictionary